FDA Asks: How Do You Paper-Trail Your Medicated Moo Juice?
Published Date: 2/25/2026
Notice
Summary
The FDA wants feedback on how medicated animal feed makers keep their records to make sure everything’s safe and up to date. This affects companies that produce medicated feeds, and they have until April 27, 2026, to share their thoughts. No big money changes yet, just a chance to improve how info is collected and stored.
Analyzed Economic Effects
5 provisions identified: 1 benefits, 4 costs, 0 mixed.
Licensed Feedmills: Large recordkeeping burden
If you run a registered, licensed commercial medicated feed mill, you must establish, maintain, and retain records under 21 CFR part 225 documenting receipts, inventory of drug components, batch production, laboratory assay results, labels, and product distribution. FDA estimates for these registered licensed commercial feed mills a total of 2,241,792 annual responses and 683,747 total annual recordkeeping hours (average 18.3 minutes or 0.305 hours per response).
Non‑licensed Mixer/Feeders: recordkeeping hours
If you run a nonregistered, non‑licensed mixer/feeder that produces medicated feeds, you must keep records under 21 CFR part 225 for components, lab controls, labeling, production, and distribution. FDA estimates 3,400 such recordkeepers producing 309,400 total annual records and requiring 420,784 total annual hours (average 1.36 hours per record).
Non‑licensed Commercial Feedmills: recordkeeping needs
If you operate a nonregistered, non‑licensed commercial feed mill that manufactures medicated feeds, you must keep records under 21 CFR part 225 for components, laboratory controls, packaging and labeling, production, and distribution. FDA estimates 1,658 recordkeepers with 150,878 total annual records and 217,265 total annual hours (average 1.44 hours per record).
Type A Medicated Article Makers: hourly burden
If you manufacture Type A medicated articles under 21 CFR part 226, you must keep records for premix components, laboratory controls, packaging, master formulas, batch production, distribution, and complaint files. FDA estimates 65 respondents generating 89,050 annual responses with about 89,050 total annual hours (approximately 1 hour per response).
FDA lowers estimated paperwork burden
FDA reports it adjusted its inventory and reduced the estimated number of medicated‑feed recordkeepers by 2,722, resulting in a decrease of 13,731,017 records and a decrease of 913,153 total annual recordkeeping hours. This change updates the compliance burden estimate for affected manufacturers.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-16296, Substances Generally Recognized as Safe
The Food and Drug Administration (FDA or we) is proposing to require the submission of generally recognized as safe (GRAS) notices for the use of a human or animal food substance purported to be GRAS under the conditions of its intended use under the Federal Food, Drug, and Cosmetic Act (FD&C Act).
2026-14073, Drug Establishment Registration and Drug Listing Requirements for Establishments Engaged in Distributed Manufacturing and Certain Foreign Establishments
The FDA wants to make it easier for drug makers who work in several locations to register as one company instead of many. They’re also updating rules for foreign drug companies to match new laws about handling health threats. If you’re in drug manufacturing, get ready to comment by September 11, 2026, and keep an eye on possible paperwork changes that could affect your business.
2026-13047, Establishment Registration and Product Listing for Tobacco Products
The FDA wants to make sure all tobacco product makers, both in the U.S. and abroad, register their businesses and list their products. This new rule closes a big gap by including foreign companies, helping the FDA keep better track of tobacco products for public health. Comments on this proposal are open until September 14, 2026, so affected businesses should get ready to update their info and possibly face new costs.
2026-16959, Frequently Asked Questions-Developing Potential Cellular and Gene Therapy Products; Final Guidance for Industry; Availability
The Food and Drug Administration (FDA or Agency) is announcing the availability of a final guidance titled "Frequently asked Questions--Developing Potential Cellular and Gene Therapy Products." The guidance document provides industry with answers to frequently asked questions (FAQs) and commonly faced issues that arise during the development of cellular and gene therapy (CGT) products. The FAQs represent common questions directed to the Agency and span multiple disciplines, including regulatory review; chemistry, manufacturing, and controls (CMC); pharmacology/toxicology; clinical; and clinical pharmacology. This guidance announced in this notice finalizes the draft guidance of the same title issued on November 19, 2024.
2026-16939, GNT USA, LLC.; Filing of Color Additive Petition
The Food and Drug Administration (FDA or we) is announcing that we have filed a petition, submitted by GNT USA, LLC., c/o Exponent, Inc., proposing that we amend our color additive regulations to provide for the safe use of safflower (Carthamus tinctorius L.) extract as a color additive in various foods at levels consistent with good manufacturing practices.
2026-16942, Food Additives Permitted in Feed and Drinking Water of Animals; Chromium DL-methionine Chelate
The Food and Drug Administration (FDA, we, or the Agency) is amending the regulations for food additives permitted in feed and drinking water of animals to provide for the safe use of chromium DL- methionine chelate as a nutritional source of chromium in cattle feed. This action is in response to a food additive petition filed by Zinpro Corp.
Previous / Next Documents
Previous: 2026-03771, Agency Information Collection Activities; Submission for Office of Management and Budget Review; Comment Request; Tobacco Retailer Training Programs
The FDA is asking for public feedback on their plan to keep collecting info about tobacco retailer training programs. These programs help stores teach employees the rules about selling tobacco safely and legally. If approved, this will continue without extra costs but keep the training standards clear and up-to-date. Comments are due by March 27, 2026, so retailers and the public can weigh in!
Next: 2026-03773, Agency Information Collection Activities; Proposed Collection; Comment Request; Biological Products: Reporting of Biological Product Deviations and Human Cells, Tissues, and Cellular and Tissue-Based Product Deviations in Manufacturing.
The FDA wants to hear from companies that make biological products and human tissues about how they report mistakes during manufacturing. They’re asking for feedback on updating the forms and rules to keep things clear and safe. If you’re involved in making these products, you’ve got until April 27, 2026, to share your thoughts—no extra costs, just a chance to help improve the process!